SLCTR_2017_033
Effect of Omega 3 Fatty Acid supplementation on hepatic steatosis and liver stiffness in patients with nonalcoholic fatty liver disease: a Randomized Controlled Trial
Department of Hepatology,Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh·Not Applicable·Sri Lanka Clinical Trials RegistryCompleted
Study focus
- Disease/Condition
- Nonalcoholic fatty liver disease (NAFLD)
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Department of Hepatology,Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh
- Location
- Bangladesh
Timeline & enrollment
- Phase
- Not Applicable
- Start date
- Jan 01, 2018
- End date
- N/A
ICD-10 classifications
Liver disease, unspecifiedInflammatory liver disease, unspecifiedAlcoholic liver disease, unspecifiedAlcoholic fatty liverToxic liver disease, unspecified
Data source
- Registry
- Sri Lanka Clinical Trials Registry
- Trial ID
- SLCTR_2017_033
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for SLCTR_2017_033 through Pure Global AI's free database. This Not Applicable trial is sponsored by Department of Hepatology,Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh and is currently Completed. The study focuses on Nonalcoholic fatty liver disease (NAFLD).
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.